Get the Stockscreener App
2.55
4.08%
0.10
Sana Biotechnology Inc Stock (SANA) Latest News
Sana Biotechnology (NASDAQ:SANA) Receives Buy Rating from HC Wainwright - MarketBeat
Sana Biotechnology to Present at December 2024 Investor Conferences - The Manila Times
Layoff Tracker: Sonata Therapeutics Laying Off 20 Employees, Changing Leadership - BioSpace
Flagship Pioneering Appoints Angela Hwang as CEO-Partner and Chief Executive Officer of Metaphore Biotechnologies - Quantisnow
Sana Biotechnology: The Story Becomes Murkier (NASDAQ:SANA) - Seeking Alpha
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sana Biotechnology, Inc.SANA - PR Newswire
Sana Biotechnology (NASDAQ:SANA) Sets New 12-Month LowShould You Sell? - MarketBeat
10 Stocks Jeff Bezos Is Buying | Investing - U.S News & World Report Money
Sana Biotechnology's SWOT analysis: stock outlook amid strategic pivot - Investing.com India
Flagship Pioneering Appoints Craig Williams as CEO-Partner and Chief Executive Officer of Apriori Bio - Quantisnow
Sana Biotechnology, Inc. (NASDAQ:SANA) Holdings Lowered by Baillie Gifford & Co. - MarketBeat
Sana Biotechnology stock hits 52-week low at $2.75 By Investing.com - Investing.com Australia
FMR LLC's Strategic Acquisition of Sana Biotechnology Inc Shares - GuruFocus.com
Sana Biotechnology stock hits 52-week low at $2.75 - Investing.com India
Sana Biotech sustains stock target with Buy rating on Q3 earnings - Investing.com Nigeria
Analyst keeps Buy on Sana Biotechnology, adjusts outlook as blood cancer competition rises - Investing.com Canada
Sana Biotechnology (NASDAQ:SANA) Hits New 1-Year LowWhat's Next? - MarketBeat
Sana Biotechnology Inc Still Hasn’t Convinced Analysts? - Stocks Register
HC Wainwright Reaffirms "Buy" Rating for Sana Biotechnology (NASDAQ:SANA) - MarketBeat
Sana Biotechnology downgraded to Market Perform from Outperform at JMP Securities - MSN
Sana Biotechnology, Inc. Reports Q3 2024 Financial Results - TipRanks
Sana: Q3 Earnings Snapshot - The Washington Post
Sana Biotechnology Inc. (SANA) Quarterly 10-Q Report - Quartzy
Earnings Flash (SANA) SANA BIOTECHNOLOGY Reports Q3 Loss $-0.27 Per Share - Marketscreener.com
Sana Biotechnology Reports Third Quarter 2024 Financial Results and Business Updates - The Manila Times
HC Wainwright Issues Positive Estimate for SANA Earnings - Defense World
HC Wainwright Issues Optimistic Forecast for SANA Earnings - MarketBeat
Sana Biotechnology refocuses on autoimmune and diabetes therapies By Investing.com - Investing.com Australia
Sana lowered to market perform by JMP over data uncertainty - MSN
Sana Biotechnology (NASDAQ:SANA) Hits New 52-Week Low on Analyst Downgrade - MarketBeat
Sana Biotechnology (NASDAQ:SANA) Price Target Lowered to $8.00 at HC Wainwright - MarketBeat
Sana Biotechnology stock hits 52-week low at $3.05 - Investing.com
Sana to lay off staff, deepen autoimmune focus in latest retrenchment - BioPharma Dive
500: Something went wrong - Investing.com UK
Sana Biotechnology stock hits 52-week low at $3.05 By Investing.com - Investing.com Canada
JMP Securities Downgrades Sana Biotechnology (NASDAQ:SANA) to Market Perform - MarketBeat
Vanguard Group Inc's Strategic Acquisition of Sana Biotechnology Inc Shares - GuruFocus.com
Sana Biotech stock target cut, buy rating held on pipeline restructuring - Investing.com UK
Sana Biotechnology refocuses on autoimmune and diabetes therapies - Investing.com
Sana Biotechnology Announces Increased Focus on Type 1 - GlobeNewswire
Sana Biotechnology (NASDAQ:SANA) Stock Price Down 6.6%Here's Why - MarketBeat
Sana Biotechnology (NASDAQ:SANA) Shares Up 7.7%Still a Buy? - MarketBeat
Sana Biotechnology (NASDAQ:SANA) Stock Price Down 6.4%What's Next? - MarketBeat
Critical Comparison: Sana Biotechnology (NASDAQ:SANA) & SAB Biotherapeutics (NASDAQ:SABS) - Defense World
Is Sana Biotechnology (NASDAQ:SANA) In A Good Position To Deliver On Growth Plans? - Yahoo Finance
Why Sana Biotechnology, Inc. (SANA) is the Penny Stock with the Biggest Upside Potential According to Analysts - Insider Monkey
1.35%
0.87%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):